1. Home
  2. LNG vs HLN Comparison

LNG vs HLN Comparison

Compare LNG & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNG
  • HLN
  • Stock Information
  • Founded
  • LNG 1983
  • HLN 2022
  • Country
  • LNG United States
  • HLN United Kingdom
  • Employees
  • LNG N/A
  • HLN N/A
  • Industry
  • LNG Oil/Gas Transmission
  • HLN Package Goods/Cosmetics
  • Sector
  • LNG Utilities
  • HLN Consumer Discretionary
  • Exchange
  • LNG Nasdaq
  • HLN Nasdaq
  • Market Cap
  • LNG 40.7B
  • HLN 47.1B
  • IPO Year
  • LNG 1997
  • HLN N/A
  • Fundamental
  • Price
  • LNG $221.99
  • HLN $9.60
  • Analyst Decision
  • LNG Strong Buy
  • HLN Strong Buy
  • Analyst Count
  • LNG 9
  • HLN 2
  • Target Price
  • LNG $210.89
  • HLN $10.48
  • AVG Volume (30 Days)
  • LNG 2.1M
  • HLN 6.5M
  • Earning Date
  • LNG 10-31-2024
  • HLN 08-01-2024
  • Dividend Yield
  • LNG 0.90%
  • HLN 1.64%
  • EPS Growth
  • LNG N/A
  • HLN N/A
  • EPS
  • LNG 15.70
  • HLN 0.18
  • Revenue
  • LNG $15,579,000,000.00
  • HLN $15,065,004,686.00
  • Revenue This Year
  • LNG N/A
  • HLN $2.92
  • Revenue Next Year
  • LNG $16.32
  • HLN $2.80
  • P/E Ratio
  • LNG $14.13
  • HLN $26.27
  • Revenue Growth
  • LNG N/A
  • HLN N/A
  • 52 Week Low
  • LNG $152.31
  • HLN $7.89
  • 52 Week High
  • LNG $225.44
  • HLN $10.80
  • Technical
  • Relative Strength Index (RSI)
  • LNG 70.43
  • HLN 46.53
  • Support Level
  • LNG $216.87
  • HLN $9.32
  • Resistance Level
  • LNG $225.44
  • HLN $9.73
  • Average True Range (ATR)
  • LNG 4.92
  • HLN 0.10
  • MACD
  • LNG 0.84
  • HLN 0.04
  • Stochastic Oscillator
  • LNG 87.12
  • HLN 78.57

About LNG Cheniere Energy Inc.

Cheniere Energy owns and operates the Sabine Pass liquefied natural gas terminal via its stake in Cheniere Partners. It also owns the Corpus Christi LNG terminals as well as Cheniere Marketing, which markets LNG using Cheniere's gas volumes.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: